Related Experiment Video
Updated: Mar 14, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Dact1, a Wnt-Pathway Inhibitor, Mediates Human Mesangial Cell TGF-β1-Induced Apoptosis
Daniele Pereira Jardim1,2, Paula Cristina Eiras Poço1, Alexandre Holthausen Campos1
1Centro de Pesquisa Experimental, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
Abstract:
Chronic kidney disease (CKD) is a worldwide public health problem that affects millions of men and women of all ages and racial groups. Loss of mesangial cells (MC) represents an early common feature in the pathogenesis of CKD. Transforming growth factor-β1 (TGF-β1) is a key inducer of kidney damage and triggers several pathological changes in renal cells, notably MC apoptosis. However, the mechanism of MC apoptosis induced by TGF-β1 remains elusive. Here, we demonstrate for the first time a novel regulatory pathway in which the disheveled-binding antagonist of β-catenin 1 (Dact1) gene is upregulated by TGF-β1, inducing MC apoptosis. We also show that the inhibitory effect of Dact1 and TGF-β1 on the transcriptional activation of the pro-survival Wnt pathway is the mechanism of death induction. In addition, Dact1 mRNA/protein levels are increased in kidney remnants from 5/6 nephrectomized rats and strongly correlate with TGF-β1 expression. Together, our results point to Dact1 as a novel element controlling MC survival that is causally related to CKD progression. J. Cell. Physiol. 232: 2104-2111, 2017. © 2016 Wiley Periodicals, Inc.
Insights
Transforming growth factor-β1 (TGF-β1) induces kidney cell death by upregulating the Dact1 gene. This novel pathway inhibits the pro-survival Wnt pathway, contributing to chronic kidney disease progression.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Chronic kidney disease (CKD) is a global health issue.
- Mesangial cell (MC) loss is an early feature of CKD pathogenesis.
- Transforming growth factor-β1 (TGF-β1) induces kidney damage and MC apoptosis, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the mechanism of TGF-β1-induced MC apoptosis.
- To identify novel regulatory pathways involved in CKD pathogenesis.
Main Methods:
- Investigated the role of disheveled-binding antagonist of β-catenin 1 (Dact1) in TGF-β1-induced MC apoptosis.
- Examined Dact1 mRNA and protein levels in a rat model of CKD (5/6 nephrectomy).
- Assessed the effect of Dact1 and TGF-β1 on Wnt pathway transcriptional activation.
Main Results:
- TGF-β1 upregulates Dact1 gene expression, leading to MC apoptosis.
- Dact1 and TGF-β1 inhibit the pro-survival Wnt pathway, mediating MC death.
- Increased Dact1 levels in kidney remnants of nephrectomized rats correlate with TGF-β1 expression.
Conclusions:
- Dact1 is a novel regulator of MC survival.
- The Dact1/TGF-β1 pathway contributes to CKD progression by inducing MC apoptosis and inhibiting the Wnt pathway.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway